Literature DB >> 25845761

Similarities of serum anti-ganglioside antibodies in first and third episodes of recurrent Guillain-Barre syndrome: case report.

Jumpei Togawa1, Yuriko Nakaoku, Mai Hagiwara, Gaku Murakami, Takahiro Mitsueda-Ono, Rino Ueno, Susumu Kusunoki, Masaru Matsui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25845761     DOI： 10.1007/s00415-015-7714-7

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

1.  Antiganglioside antibodies in various episodes in a patient with recurrent Guillain-Barré syndrome.

Authors:  Y Tagawa; N Yuki; K Hirata
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

2.  Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Dutch Guillain-Barré study group.

Authors:  L H Visser; F G van der Meché; J Meulstee; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

3.  The recurrent Guillain-Barré syndrome: a long-term population-based study.

Authors:  N Mossberg; M Nordin; C Movitz; S Nilsson; K Hellstrand; T Bergström; B Andersson; O Andersen
Journal:  Acta Neurol Scand       Date:  2012-04-17       Impact factor: 3.209

4.  Recurrent Guillain-Barré syndrome.

Authors:  K Kuitwaard; R van Koningsveld; L Ruts; B C Jacobs; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10-17       Impact factor: 10.154
  4 in total
  1 in total

1.  An Adult Case of Recurrent Guillain-Barré Syndrome with Anti-galactocerebroside Antibodies.

Authors:  Hisashi Takahashi; Tadashi Kimura; Natsuko Yuki; Akira Yoshioka
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.